Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 40814472.
- Also identified by DOI 10.4103/jfmpc.jfmpc_1984_24 and PMC identifier 12349861.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited. This study aimed to identify risk factors for COVID-19-associated mucormycosis. A case-control study was conducted in the Nagpur district. Cases were recruited from suspected or confirmed mucormycosis cases reported to district health authorities. Controls were household members who had COVID-19 but did not develop mucormycosis. Predisposing and treatment-related factors were analyzed. Analysis revealed significant associations between mucormycosis and diabetes mellitus (OR-10.8; CI-1.1-103.6) and corticosteroid use (OR-97.6; CI-3.2-2927.1). Factors such as humidifier use and mask usage did not show a significant association. Optimal use of oxygen and corticosteroids is crucial, particularly in diabetic COVID-19 patients, to prevent mucormycosis.